Background This study evaluated the pharmacokinetics of dolutegravir in HIV-infected infants receiving twice-daily (BID) dolutegravir with rifampicin-based tuberculosis (TB) treatment compared to once-daily (OD) dolutegravir [...]
The 5th Annual Meeting of the EMPIRICAL Project was held on April 9-10, 2024, at the Novotel Hotel in Madrid. This significant event followed the [...]
First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia Chishala Chabala, Tom G. Jacobs, Cinta Moraleda, John [...]
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial Tom G. Jacobs,1,a, Vivian Mumbiro,2,a Uneisse Cassia,3 Kevin Zimba,4 [...]
La Unidad de Enfermedades Infecciosas aporta por primera vez información sobre este tratamiento en lactantes menores de un año, probado en adultos y niños mayores [...]